Affirming Gender Identity From the Start

New Jersey recently made a groundbreaking decision to allow gender-affirming care for fetuses that show signs of gender dysphoria in utero. While the incidence rate is unknown, this proactive step recognizes that gender identity can develop before birth and affirms the rights of transgender individuals from the very beginning.

For those unfamiliar with the term, gender dysphoria refers to psychological distress that results from an incongruence between one's sex assigned at birth and one's gender identity. It is a serious condition that, when left untreated, puts transgender individuals at higher risk of anxiety, depression, and even suicidal ideation. The medical consensus is that gender-affirming care is crucial and medically necessary.

While gender dysphoria has historically been diagnosed in childhood or later, we now understand that gender identity begins forming in utero. Just as some children consistently, insistently express their gender identity from a very young age, it reasons that gender dysphoria may manifest during gestation. Allowing gender-affirming interventions at this earliest stage prevents subjecting transgender individuals to an identity inconsistent with their core self.

The procedures under consideration are safe, ethical, and reversible if ultimately unnecessary. They include low-dose hormone therapy and other treatments to pause gendered biological development until after birth when the child can actively participate in decisions about their transition. Fetuses with ambiguous genitalia may also receive gender-affirming genital reconstructions.

Critics argue we are prematurely medicalizing gender identity and stripping children of autonomy over profound life decisions. But the alternative - forcing children to be raised as a gender they do not identify with - is the greater ethical breach. We already make immense decisions about our children's identity from naming them to assigning gender markers. Affirming their core self is the compassionate choice.

Some also question the ability to diagnose gender dysphoria in utero. While the science is still emerging, we already use advanced prenatal testing and imagery to detect developmental conditions like Down syndrome. If we can identify intersex traits, it follows we may detect transgender identity. Even if the diagnosis is imperfect, the care is fully reversible and errs on the side of preventing psychological trauma.

Fundamentally, this is about human rights. We do not infringe on children's autonomy by allowing them to be themselves. Gender-affirming care is medically endorsed to alleviate dysphoria and uphold the dignity of transgender individuals. New Jersey's policy is a progressive, ethical, and scientifically-grounded step in this direction. As our understanding of gender identity evolves, so must our practices to affirm the identities of all people from their first moments.